We are strong manufacturer of Impurity,we have largest variety of impurities are available in stock. we have more than 5001+ impurity available in stock.. If you have any requirement of Impurities please let us know. We offer impurities below the market rate due to our commercial production technology , this will help you to save cost of 30-45% of your organisation.​

1. Diclofenac impurity A impurity manufacturer and supplier
RXN CHEMICALS PVT LTD., situated at Navi Mumbai, India which is in the business of
manufacturing and supplying of Pharmaceutical Impurities, Drug Impurity, Drug Metabolites,
Reference Standard Compound, and APIs.
We have manufactured Diclofenac impurity A Impurity. It is fully characterized using HPLC,
LC-MS, 1H NMR spectra and COA and is confirmed with RT, RRT and RF.
We also perform custom synthesis and purification of Diclofenac impurity A impurity from mg to
gm scale.
Diclofenac impurity A Impurity
We also perform custom synthesis and purification of impurity from mg to gm scale, isolation of
unknown impurity from drug product and APIs, structure elucidation as requested by our clients.
From past 5 years we have been supporting all Domestic markets for Impurities & API in USA,
Impurities & API in Canada and Impurities & API European countries. Rxn Chemicals can
support for all Impurities which are acceptable to all regulatory agencies in the world, US-FDA,
MHRA, MCC, WHO, Brazil, Japan.
Rxn Chemicals is manufacturer and supplier of unknown Impurity of Diclofenac impurity A
impurity which can be used for ANDA filing/DMF filing also in genotoxic study and
pharmacological studies
Please feel free to keep in touch with us about any of your business related requirements /
inquiries. We would like to offer our service to your company. We will contact you for further
discussion at a time which is convenient to you.
We look forward to a wonderful relationship together and success for all concerned.
Write to us on the info@rxnchem.com email id to get discounted quote or visit us
at www.rxnchem.coM
08/03/2016